Merck | MRK - Assets


Merck reported EUR53.07B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Adidas EUR 21.06B 610M Jun/2026
Adyen EUR 12.26B 1.68B Dec/2025
Akzo Nobel EUR 16.13B 647M Jun/2026
Alcon AG USD 31.62B 64M Mar/2026
Amadeus IT EUR 11.76B 332.2M Jun/2026
Amarin USD 624.36M 21.4M Jun/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
BASF EUR 83.87B 2.1B Jun/2026
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
Covestro EUR 13.47B 245M Dec/2025
Danone EUR 48.62B 3.55B Jun/2026
Fresenius EUR 42.37B 975M Mar/2026
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Henkel EUR 32.53B 258M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Infineon EUR 31.72B 978M Mar/2026
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Linde USD 86.32B 502M Mar/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 122.03B 3.5B Jun/2026
Philips EUR 26.7B 565M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
UCB EUR 18.16B 971M Dec/2025